Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (301-310 of 692) with videos related to

Pageof 70
Sort By:
Cancer|December 1, 1993
Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trialR J Motzer, E Dmitrovsky, W H Miller, et al.
ESMO Open|November 13, 2020
Impact of clinical versus radiographic progression on clinical outcomes in metastatic castration-resistant prostate cancerArpit Rao, Howard I Scher, Peter De Porre, et al.
Cephalalgia : an International Journal of Headache|July 13, 2018
Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyAnn I Scher, Shuu-Jiun Wang, Zaza Katsarava, et al.
Prostate Cancer and Prostatic Diseases|March 5, 2004
Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapyD E Orange, M Jegathesan, N E Blachère, et al.
The Journal of Experimental Medicine|March 1, 1982
Role of the thymus in directing the development of a subset of B lymphocytesJ J Mond, I Scher, J Cossman, et al.
Prostate Cancer and Prostatic Diseases|March 19, 2014
Androgen dynamics and serum PSA in patients treated with abiraterone acetateC J Ryan, W Peng, T Kheoh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Bicalutamide for advanced prostate cancer: the natural versus treated history of diseaseH I Scher, C Liebertz, W K Kelly, et al.
Nature Reviews. Urology|February 21, 2018
Clinical implications of PTEN loss in prostate cancerTamara Jamaspishvili, David M Berman, Ashley E Ross, et al.
Cancer Research|October 16, 1999
Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft modelsD B Agus, H I Scher, B Higgins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failureAlexandra J Stewart, Howard I Scher, Ming-Hui Chen, et al.
Pageof 70

Showing results (301-310 of 692) with videos related to

Sort By:
Pageof 70
Cancer|December 1, 1993
Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trialR J Motzer, E Dmitrovsky, W H Miller, et al.
ESMO Open|November 13, 2020
Impact of clinical versus radiographic progression on clinical outcomes in metastatic castration-resistant prostate cancerArpit Rao, Howard I Scher, Peter De Porre, et al.
Cephalalgia : an International Journal of Headache|July 13, 2018
Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyAnn I Scher, Shuu-Jiun Wang, Zaza Katsarava, et al.
Prostate Cancer and Prostatic Diseases|March 5, 2004
Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapyD E Orange, M Jegathesan, N E Blachère, et al.
The Journal of Experimental Medicine|March 1, 1982
Role of the thymus in directing the development of a subset of B lymphocytesJ J Mond, I Scher, J Cossman, et al.
Prostate Cancer and Prostatic Diseases|March 19, 2014
Androgen dynamics and serum PSA in patients treated with abiraterone acetateC J Ryan, W Peng, T Kheoh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Bicalutamide for advanced prostate cancer: the natural versus treated history of diseaseH I Scher, C Liebertz, W K Kelly, et al.
Nature Reviews. Urology|February 21, 2018
Clinical implications of PTEN loss in prostate cancerTamara Jamaspishvili, David M Berman, Ashley E Ross, et al.
Cancer Research|October 16, 1999
Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft modelsD B Agus, H I Scher, B Higgins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failureAlexandra J Stewart, Howard I Scher, Ming-Hui Chen, et al.
Pageof 70